SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001136261-19-000068
Filing Date
2019-02-19
Accepted
2019-02-19 08:00:27
Documents
4
Period of Report
2019-02-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K body8k.htm 8-K 18635
2 ASSET PURCHASE AGREEMENT, DATED FEBRUARY 15, 2019, BY AND BETWEEN SEELOS THERAPE exh2-1.htm EX-2.1 71812
3 PRESS RELEASE exh99-1.htm EX-99.1 10706
4 LOGO image3903.jpg GRAPHIC 4394
  Complete submission text file 0001136261-19-000068.txt   108642
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 19613449
SIC: 2834 Pharmaceutical Preparations